Tech Company Financing Transactions
Trailhead Biosystems Funding Round
Private investors participated in a $10 million Series A funding round for Trailhead Biosystems. This VC investment round closed on 10/11/2022.
Transaction Overview
Company Name
Announced On
10/11/2022
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
This round of funding will enable the company to complete its fit-out providing a total of ~15,000 sqft headquarters in Greater Cleveland Ohio, including laboratory, tissue culture, bioreactor manufacturing, and bioinformatics facilities, allowing us to sustain continued and scaled development of human cells and deliver them to industry and clinical partners.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
10000 Cedar Ave.
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Not Recorded
Overview
Trailhead Biosystems is pioneering the development of cell-based therapeutics using machine learning and bioinformatics. Trailhead's High Dimensional Design of Experiments (HD-DoE) platform merges developmental biology and cell therapeutics with advanced robotics, computerized experimental design, and analysis to perform process-specific parameter optimization in the development of cell therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Magnus Persson
Chief Executive Officer
Jan Jensen
Chief Operating Officer
Div Trivedi
Browse more venture capital transactions:
Prev: 10/11/2022: Elenas venture capital transaction
Next: 10/11/2022: YardLink venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs